Tag: Vvital Biomed

Cardio Industry Executive Ed Rieflin Appointed to Chair Vvital Biomed

Ed Rieflin brings 19 years of leadership experience from Thoratec, St. Jude Medical and Abbott Laboratories to advance Vvital’s mitral valve solution MISGAV, Israel, April 7, 2021 /PRNewswire/ —  Vvital Biomed Ltd. (“Vvital”), a portfolio company of The Trendlines Group (SGX: 42T) (OTCQX: TRNLY), announced the appointment of Ed Rieflin as Chair of the Board. Ed brings […]